ACADIA Pharmaceuticals Inc - Trending symbols
Trends
| 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Other Comprehensive Income | -975 | 755 | -220 | -315 | -535 | 216 | -319 | 343 | 24 | |
| Income before Tax | -33,568 | 7,153 | -26,415 | -14,475 | -40,890 | -4,049 | -44,939 | 51,282 | 6,343 | |
| Net Income | -34,011 | 6,828 | -27,183 | -14,542 | -41,725 | -1,296 | -43,021 | 44,135 | 1,114 | |
| EBITDA | -33,651 | 2,785 | -30,866 | -15,197 | -46,063 | -7,521 | -53,584 | 56,621 | 3,037 | |
| Operating Income | -33,651 | 2,785 | -30,866 | -15,197 | -46,063 | -7,521 | -53,584 | 56,621 | 3,037 | |
| Total Other Income Expense Net | 83 | 4,368 | 4,451 | 722 | 5,173 | 3,472 | 8,645 | -9,889 | -1,244 | |
| Net Income from Continuing Operations | -34,011 | 6,828 | -27,183 | -14,542 | -41,725 | -1,296 | -43,021 | 44,135 | 1,114 | |
| EBIT | -34,166 | 2,794 | -31,372 | -15,180 | -46,552 | -7,458 | -54,010 | 55,281 | 1,271 | |
| Tax Provision | 485 | -42 | 443 | 325 | 768 | 67 | 835 | -2,753 | -1,918 | |
| Income Tax Expense | 485 | -42 | 443 | 325 | 768 | 67 | 835 | -2,753 | -1,918 | |
| Interest Expense | 105 | 475 | 580 | 1,715 | 2,295 | 1,335 | 3,630 | -12,701 | -9,071 | |
| Depreciation and Amortization | 535 | -19 | 516 | -1 | 515 | -9 | 506 | -2,753 | -2,247 |
Comments
How you think about this?